Cargando…
Neuroprotective effects of erythropoietin against hypoxic injury via modulation of the mitogen-activated protein kinase pathway and apoptosis
PURPOSE: Hypoxic-ischemic encephalopathy is a significant cause of neonatal morbidity and mortality. Erythropoietin (EPO) is emerging as a therapeutic candidate for neuroprotection. Therefore, this study was designed to determine the neuroprotective role of recombinant human EPO (rHuEPO) and the pos...
Autores principales: | Jeong, Ji Eun, Park, Jae Hyun, Kim, Chun Soo, Lee, Sang Lak, Chung, Hai Lee, Kim, Woo Taek, Lee, Eun Joo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Pediatric Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500386/ https://www.ncbi.nlm.nih.gov/pubmed/28690645 http://dx.doi.org/10.3345/kjp.2017.60.6.181 |
Ejemplares similares
-
The neuroprotective effect of recombinant human erythropoietin via an antiapoptotic mechanism on hypoxic-ischemic brain injury in neonatal rats
por: Kim, Moon Sun, et al.
Publicado: (2010) -
Biphasic Regulation of Mitogen-Activated Protein Kinase Phosphatase 3 in Hypoxic Colon Cancer Cells
por: Kim, Hong Seok, et al.
Publicado: (2021) -
The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage
por: Yoo, Seung-Jun, et al.
Publicado: (2017) -
Role of Nuclear-Receptor-Related 1 in the Synergistic Neuroprotective Effect of Umbilical Cord Blood and Erythropoietin Combination Therapy in Hypoxic Ischemic Encephalopathy
por: Choi, Joo-Wan, et al.
Publicado: (2022) -
Second-generation non-hematopoietic erythropoietin-derived peptide for neuroprotection
por: Cho, Bongki, et al.
Publicado: (2021)